UNC
The company plans to publish new data on clinical sensitivity and specificity and has initiated multiple studies investigating new use cases.
FDA Grants EUAs to Coronavirus Tests From Orig3n, SDI, UNC
The FDA has also granted emergency use authorization for PCR-based tests for SARS-CoV-2 developed by Orig3n, Specialty Diagnostic Laboratories (SDI), and the University of North Carolina (UNC) Medical Center.
HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch
Premium
The company began offering testing to clinicians in the first quarter of this year and expects volume to grow significantly over the next several months.
Interpace Biosciences, University of North Carolina Launch Barrett's Esophagus Study
As part of the collaboration, UNC will use the firm's BarreGen assay to target molecular changes to predict resistance or relapse following ablation.
Sexually Transmitted Infectious Disease Dx Testing Gains Traction in Clinics, at Point of Care
Premium
Developers of POC STI platforms and assays said that the tests provide convenience, privacy, and quick results in an area of testing in need of these benefits.